2027 Deadlines Confirmed for MRC Impact Acceleration Awards

Funding available to develop a new or repurposed medicine, medical device, diagnostic, or other medical product.

The Medical Research Council (MRC) provides the UKRI Translation: MRC Impact Acceleration Awards – formerly the ‘Gap Fund: single-step support for medical product development’ – for academically-led translational projects that aim to undertake a single-step package of development work that will bridge the gap between the inception of a new idea and substantive funding through schemes such as the MRC Proof of concept funding opportunity (formerly Developmental Pathway Funding Scheme, DPFS).

This scheme is designed will provide small-scale funding to generate critical data needed prior to seeking more substantive funding. It supports the development of a new or repurposed medicine, medical device, diagnostic, or other medical product. Projects must target a high-risk development step backed by prior funding, generating critical data to de-risk onward progression or determine failure.

The awards will only support single-step projects, focusing on one goal rather than multiple steps. Submitted projects should have already explored a new concept and generated some data in support of the approach.

All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues.

Applications are open to organisations with standard eligibility. Individuals must meet individual eligibility criteria. Applicants can only act as project lead on one application submitted to this funding opportunity.

A total of £3 million is available at 80% full economic cost (FEC). Individual projects can request between £50,000 and £300,000 at 80% FEC and 100% of permitted exceptions. Projects should last between 6 and 18 months.

The 2027 deadlines are as follows:

  • 10 March 2027
  • 14 July 2027
  • 10 November 2027

Contact us

Find out more about ResearchConnect